Abstract
Microalbuminuria is an established cardiovascular risk indicator in diabetes, hypertension and the general population. There is lack of information on MAU in healthy obese Indian adults and an ongoing debate whether obese adults deserve targeted identification and clinical intervention for MAU and prediabetes. We aimed to screen the healthy obese, young (group I) and middle aged (group II) adults for prevalence of MAU and prediabetes and study its association with Framingham risk score. The study included 50 healthy obese young (20–30 years) and middle aged adults (31–50 years), attending the outpatient clinic of Dept. of Medicine for a duration of 2 months (July–August). The patients were screened for fasting blood sugar, lipid profile and MAU. Of the total patients 28 % had MAU, 32.14 % of which had prediabetes and 33.33 % had diabetes whereas 10 % were normoglycemic. The group I patients had 50 % cases of MAU and group II had 25 % patients with MAU. Group II 63.63 % pre-diabetics. The values of MAU obtained were correlated with age, gender, body mass index, systolic and diastolic blood pressure, FBS, waist to hip ratio using Pearson’s Coefficient (p < 0.05). The 10 year CVD risk calculated using FRS in subjects with MAU was higher as compared to those without MAU. Thus we conclude that Indian, young and middle aged obese adults to be at a risk of prediabetes, MAU and CV risk warranting their routine screening for better clinical outcomes.
References
Thoenes M, Reil JC, Khan BV, Bramlage P, Volpe M, Kirch W, et al. Abdominal obesity is associated with MAU and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag. 2009;5:577–85.
Minoo F, Mazdeh MM, Abbasi MR, Sohrabi S. Impact of the severity of obesity on microalbuminuria in obese normotensive nondiabetic individuals. J Renal Inj Prev. 2015;4(2):34–8.
Thoenes M, Bramlage P, Khan BV, Schieffer B, Kirch W, Weir MR. Albuminuria: pathophysiology, epidemiology and clinical relevance of an emerging marker for cardiovascular disease. Future Cardiol. 2007;3:519–24.
Sharma P, Mishra S. Metabolic syndrome: early identification prevents type II diabetes and cardiovascular disease. Ind J Clin Biochem. 2007;22(1):1–3.
Khaodhiar L, Cummings S, Apovian CM. Treating diabetes and prediabetes by focussing on obesity management. Curr Diabetes Rep. 2009;9(5):348–54.
Grundy S. Prediabetes, metabolic syndrome and cardiovascular risk. J Am Coll Cardiol. 2012;59(7):635–43.
Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–52.
Wang Z, Wang FF, Zhu XJ, Luo JJ, Han Y, Pan XP, et al. Metabolic syndrome and microalbuminuria accompanied accompanied with hyperglycemia in community subjects. Zhonghua Yi Xue Za Zhi. 2012;92(36):2526–9.
Chang Y, Yoo T, Ryu S, Huh BY, Cho BL, Sung E, et al. Abdominal obesity, SBP, and microalbuminuria in normotensive and euglycemic Korean men. Int J Obes (Lond). 2006;30(5):800–4.
Konno S, Hozawa A, Miura Y, Ito S, Munakata M. High-normal DBP is a risk for development of microalbuminuria in the general population: the Watari study. J Hypertens. 2013;31(4):798–804.
Pavan M, Ranganath R, Chaudhari AP, Shetty M. Obesity as an independent risk factor for the development of MAU. Nephro-Urol Mon. 2011;3(4):276–9.
Bansal M, Mehrotra R, Kasliwal RR. Cardiovascular risk stratification in Indians. J Clin Prev Cardiol. 2015;4(1):7–17.
Bartz SK, Caldas MC, Tomsa A, Krishnamurthy R, Bacha F. Urine albumin-to-creatinine ratio: a marker of early endothelial dysfunction in youth. J Clin Endocrinal Metab. 2015;100(9):3393–9. doi:10.1210/JC.2015-2230.
Bertoluci MC, Ce GV, da Silva AM, Wainstein MV, Boff W, Punales M. Endothelial dysfunction as a predictor of cardiovascular disease. World J Diabetes. 2015;6(5):679–92. doi:10.4239/wjd.v6.i5.679.
Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol. 2007;2:581–90.
Acknowledgments
The project was awarded the Short term studentship—Indian Council of Medical Research (STS-ICMR) for the year 2014–15.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Purvi Purohit, Kunal Garg, Vikram Singh, Shailendra Dwivedi and Praveen Sharma declare that they have no conflict of interest.
Ethical Standard
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Human and Animal Rights
This article does not contain any studies with animals performed by any of the authors.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Purohit, P., Garg, K., Singh, V. et al. Microalbuminuria in Obese Young and Middle Aged Population: A Potential Marker of Cardiovascular Risk. Ind J Clin Biochem 31, 349–352 (2016). https://doi.org/10.1007/s12291-016-0563-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-016-0563-z